134 related articles for article (PubMed ID: 38180954)
1. Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Alden SL; Lee V; Narang AK; Meyer J; Gearhart SL; Christenson ES
Oncologist; 2024 Mar; 29(3):e414-e418. PubMed ID: 38180954
[TBL] [Abstract][Full Text] [Related]
2. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer.
McDuff SGR; Hardiman KM; Ulintz PJ; Parikh AR; Zheng H; Kim DW; Lennerz JK; Hazar-Rethinam M; Van Seventer EE; Fetter IJ; Nadres B; Eyler CE; Ryan DP; Weekes CD; Clark JW; Cusack JC; Goyal L; Zhu AX; Wo JY; Blaszkowsky LS; Allen J; Corcoran RB; Hong TS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250394
[TBL] [Abstract][Full Text] [Related]
4. Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study.
Zhou J; Wang C; Lin G; Xiao Y; Jia W; Xiao G; Liu Q; Wu B; Wu A; Qiu H; Zhang F; Hu K; Xue H; Shen Z; Wang Z; Han J; Niu B; Xu Y; Yu Z; Yang L
Clin Cancer Res; 2021 Jan; 27(1):301-310. PubMed ID: 33046514
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial.
Vidal J; Casadevall D; Bellosillo B; Pericay C; Garcia-Carbonero R; Losa F; Layos L; Alonso V; Capdevila J; Gallego J; Vera R; Salud A; Martin-Richard M; Nogué M; Cillán E; Maurel J; Faull I; Raymond V; Fernández-Martos C; Montagut C
Clin Cancer Res; 2021 May; 27(10):2890-2898. PubMed ID: 33727257
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer.
Hofste LSM; Geerlings MJ; von Rhein D; Rütten H; Westenberg AH; Weiss MM; Gilissen C; Hofste T; van der Post RS; Klarenbeek BR; de Wilt JHW; Ligtenberg MJL;
Eur J Surg Oncol; 2023 Jul; 49(7):1283-1290. PubMed ID: 36740555
[TBL] [Abstract][Full Text] [Related]
7. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
8. ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.
Morais M; Pinto DM; Machado JC; Carneiro S
Eur J Surg Oncol; 2022 Jan; 48(1):218-227. PubMed ID: 34511270
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
10. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer.
Eyck BM; Jansen MP; Noordman BJ; Atmodimedjo PN; van der Wilk BJ; Martens JW; Helmijr JA; Beaufort CM; Mostert B; Doukas M; Wijnhoven BP; Lagarde SM; van Lanschot JJB; Dinjens WN
J Pathol; 2023 Jan; 259(1):35-45. PubMed ID: 36196486
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
13. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
14. Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer.
Iafrate F; Ciccarelli F; Masci GM; Grasso D; Marruzzo F; De Felice F; Tombolini V; D'Ambrosio G; Magliocca FM; Cortesi E; Catalano C
Eur Radiol; 2023 Feb; 33(2):854-862. PubMed ID: 35980431
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
Chang L; Zhang X; He L; Ma Q; Fang T; Jiang C; Ma Z; Li Q; Wu C; Tao J
Oncologist; 2023 Dec; 28(12):e1198-e1208. PubMed ID: 37294663
[TBL] [Abstract][Full Text] [Related]
16. Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence.
Murahashi S; Akiyoshi T; Sano T; Fukunaga Y; Noda T; Ueno M; Zembutsu H
Br J Cancer; 2020 Sep; 123(5):803-810. PubMed ID: 32565539
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
[TBL] [Abstract][Full Text] [Related]
18. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.
Jayaprakasam VS; Paroder V; Gibbs P; Bajwa R; Gangai N; Sosa RE; Petkovska I; Golia Pernicka JS; Fuqua JL; Bates DDB; Weiser MR; Cercek A; Gollub MJ
Eur Radiol; 2022 Feb; 32(2):971-980. PubMed ID: 34327580
[TBL] [Abstract][Full Text] [Related]
19. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.
O'Sullivan NJ; Temperley HC; Kyle ET; Sweeney KJ; O'Neill M; Gilham C; O'Sullivan J; O'Kane G; Mehigan B; O'Toole S; Larkin J; Gallagher D; McCormick P; Kelly ME
Int J Colorectal Dis; 2024 May; 39(1):82. PubMed ID: 38809315
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
[Next] [New Search]